The corticosteroid methylprednisolone doesn’t improve survival in patients with late-stage acute respiratory distress syndrome (ARDS), according to an NIH-sponsored trial. (April 20 issue of the New England Journal of Medicine)
The corticosteroid methylprednisolone doesn’t improve survival in patients with late-stage acute respiratory distress syndrome (ARDS), according to an NIH-sponsored trial. (April 20 issue of the New England Journal of Medicine)
